Paper19681102
Acute stroke therapy with tissue plasminogen activator (tPA) since it was approved by the U.S. Food and Drug Administration (FDA).
Zivin JA. Ann Neurol, 2009. Cited by 101 papers, by iCite.
Cite this record
ConductScience Library. Acute stroke therapy with tissue plasminogen activator (tPA) since it was approved by the U.S. Food and Drug Administration (FDA). Papers, record 19681102. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19681102
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Acute stroke therapy with tissue plasminogen activator (tPA) since it was approved by the U.S. Food and Drug Administration (FDA).
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Stroke | Major topic |
| Tissue Plasminogen Activator | Major topic |
| United States Food and Drug Administration | Major topic |
| Drug Approval | |
| History, 20th Century | |
| History, 21st Century | |
| Humans | |
| United States |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT03519737 | Aureva Transcranial Ultrasound Device With tPA in Patients With Acute Ischemic Stroke | Background |
Source ClinicalTrials.gov
Cited by63
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 101 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42432671 | The role of AI-assisted drug repurposing in neurological disorders: a systematic review of validation strategies, challenges and opportunities. | J Nanobiotechnology | 2026 | https://conductscience.org/library/papers/42432671 | PubMed |
| 40143813 | PA System in the Pathogenesis of Ischemic Stroke. | Arterioscler Thromb Vasc Biol | 2025 | https://conductscience.org/library/papers/40143813 | PubMed |
| 38487357 | Thrombolytic Therapy for Central Retinal Artery Occlusion in an Academic Multi-Site Stroke Centre. | Neuroophthalmology | 2024 | https://conductscience.org/library/papers/38487357 | PubMed |
| 38424568 | Evaluating the effects of simulation training on stroke thrombolysis: a systematic review and meta-analysis. | Adv Simul (Lond) | 2024 | https://conductscience.org/library/papers/38424568 | PubMed |
| 38371456 | Extracellular Vesicles Maintain Blood-Brain Barrier Integrity by the Suppression of Caveolin-1/CD147/VEGFR2/MMP Pathway After Ischemic Stroke. | Int J Nanomedicine | 2024 | https://conductscience.org/library/papers/38371456 | PubMed |
| 38317779 | Transcranial photobiomodulation for brain diseases: review of animal and human studies including mechanisms and emerging trends. | Neurophotonics | 2024 | https://conductscience.org/library/papers/38317779 | PubMed |
| 38030932 | Novel Programmed Death Ligand 1-AKT-engineered Mesenchymal Stem Cells Promote Neuroplasticity to Target Stroke Therapy. | Mol Neurobiol | 2024 | https://conductscience.org/library/papers/38030932 | PubMed |
| 37765291 | The Recent Applications of PLGA-Based Nanostructures for Ischemic Stroke. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/37765291 | PubMed |
| 37443691 | Brain-Derived Neurotrophic Factor (BDNF) and Translocator Protein (TSPO) as Diagnostic Biomarkers for Acute Ischemic Stroke. | Diagnostics (Basel) | 2023 | https://conductscience.org/library/papers/37443691 | PubMed |
| 37326791 | Neutralizing RGMa with Elezanumab Promotes Cerebroprotection and Recovery in Rabbit Middle Cerebral Artery Occlusion. | Transl Stroke Res | 2024 | https://conductscience.org/library/papers/37326791 | PubMed |
| 37289370 | The potential role of micro-RNA 125b-5p level in predicting outcome from thrombolytic therapy in patients with acute ischemic stroke. | J Thromb Thrombolysis | 2023 | https://conductscience.org/library/papers/37289370 | PubMed |
| 36714223 | Phenomic Studies on Diseases: Potential and Challenges. | Phenomics | 2023 | https://conductscience.org/library/papers/36714223 | PubMed |
| 35283994 | Brain-Derived Neurotrophic Factor and Nerve Growth Factor Therapeutics for Brain Injury: The Current Translational Challenges in Preclinical and Clinical Research. | Neural Plast | 2022 | https://conductscience.org/library/papers/35283994 | PubMed |
| 35281985 | Safety of Intraparenchymal Injection of Allogenic Placenta Mesenchymal Stem Cells Derived Exosome in Patients Undergoing Decompressive Craniectomy Following Malignant Middle Cerebral Artery Infarct, A Pilot Randomized Clinical Trial. | Int J Prev Med | 2022 | https://conductscience.org/library/papers/35281985 | PubMed |
| 35243774 | Potential nanotherapeutic strategies for perioperative stroke. | CNS Neurosci Ther | 2022 | https://conductscience.org/library/papers/35243774 | PubMed |
| 35218497 | Recycled Translation: Repurposing Drugs for Stroke. | Transl Stroke Res | 2022 | https://conductscience.org/library/papers/35218497 | PubMed |
| 35052603 | Prunus cerasoides Extract and Its Component Compounds Upregulate Neuronal Neuroglobin Levels, Mediate Antioxidant Effects, and Ameliorate Functional Losses in the Mouse Model of Cerebral Ischemia. | Antioxidants (Basel) | 2021 | https://conductscience.org/library/papers/35052603 | PubMed |
| 33830432 | The use of recombinant tissue plasminogen activator in in acute ischemic stroke is associated with increased level of BDNF. | J Thromb Thrombolysis | 2021 | https://conductscience.org/library/papers/33830432 | PubMed |
| 33730305 | Caffeine and Its Neuroprotective Role in Ischemic Events: A Mechanism Dependent on Adenosine Receptors. | Cell Mol Neurobiol | 2022 | https://conductscience.org/library/papers/33730305 | PubMed |
| 33707580 | Development of a photochemical thrombosis investigation system to obtain a rabbit ischemic stroke model. | Sci Rep | 2021 | https://conductscience.org/library/papers/33707580 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| PLAT | 5327 | PubTator's text mining | https://conductscience.org/library/genes/5327 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19681102
GET https://conductscience.org/api/papers/v1/19681102/cited_by?page=2